Mark O’Neill
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Molecular Biology top 5%
- Metabolism, Diabetes, and Cancer
- Peroxisome Proliferator-Activated Receptors
Papers in
-
- Child Nutrition and Feeding Issues 5
- Cerebral Palsy and Movement Disorders 2
-
- Metabolism, Diabetes, and Cancer 3
- Peroxisome Proliferator-Activated Receptors 2
- Co-authors
- Bernard Zinman (3 shared papers)Steven E. Kahn (3 shared papers)Steven M. Haffner (3 shared papers)Mark Heise (3 shared papers)Barbara G. Kravitz (3 shared papers)Nigel C. Jones (2 shared papers)Rury R. Holman (2 shared papers)Giancarlo Viberti (2 shared papers)
- Journals
- Diabetes Obesity and Metabolism (2 papers)Diabetes (2 papers)Developmental Medicine & Child Neurology (2 papers)Clinical Chemistry (1 paper)BMJ Open (1 paper)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Mark O’Neill
12 papers receiving 2.5k citations
Mark O’Neill's Hit Papers
Peers
Comparison fields: 5 of 93
- Endocrinology, Diabetes and Metabolism 2.0k
- Molecular Biology 1.3k
- Surgery 807
- Pharmacology 228
- Physiology 300
Countries citing papers authored by Mark O’Neill
This map shows the geographic impact of Mark O’Neill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark O’Neill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark O’Neill more than expected).
Fields of papers citing papers by Mark O’Neill
This network shows the impact of papers produced by Mark O’Neill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark O’Neill. The network helps show where Mark O’Neill may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark O’Neill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy Hit paper breakdown → | 2006 | 2202 |
| 2 | 2006 | 149 | |
| 3 | 2004 | 143 | |
| 4 | 2005 | 52 | |
| 5 | 2019 | 21 | |
| 6 | 2021 | 14 | |
| 7 | 2023 | 9 | |
| 8 | 2019 | 9 | |
| 9 | 2014 | 9 | |
| 10 | 2023 | 3 | |
| 11 | 1987 | 3 | |
| 12 | 2023 | 2 | |
| 13 | 2023 | 0 |
About Mark O’Neill
Mark O’Neill is a scholar working on Psychiatry and Mental health, Molecular Biology, Endocrinology, Diabetes and Metabolism, Nutrition and Dietetics and Surgery, having authored 13 papers that have together received 2.6k indexed citations. Recurring topics across this work include Child Nutrition and Feeding Issues (5 papers), Clinical Nutrition and Gastroenterology (4 papers), Metabolism, Diabetes, and Cancer (3 papers), Diabetes Treatment and Management (3 papers), Pancreatic function and diabetes (2 papers), Cerebral Palsy and Movement Disorders (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.0k citations), Molecular Biology (1.3k citations), Surgery (807 citations), Pharmacology (228 citations) and Physiology (300 citations). Mark O’Neill has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Bernard Zinman, Steven E. Kahn, Steven M. Haffner, Mark Heise, Barbara G. Kravitz, Nigel C. Jones, Rury R. Holman, Giancarlo Viberti, John M. Lachin and William H. Herman. Their work appears in journals such as Diabetes Obesity and Metabolism, Diabetes, Developmental Medicine & Child Neurology, Clinical Chemistry and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.